ROIV

SEC source: 0001140361-25-046786 · form4.xml · derivative · entry 5

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,562,682

Underlying: Common Stock · 313,841 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001140361-25-046786 · form4.xml · nonDerivative · entry 2

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,611,749

F1 · shares: Represents an exercise and hold transaction, with a sale of Common Shares only to cover applicable withholding taxes and the exercise price of the stock options exercised.

F2 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F3 · price: These Common Shares were sold in multiple transactions at prices ranging from $22.25 to $22.64, inclusive.

SEC source: 0001140361-25-046786 · form4.xml · nonDerivative · entry 1

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,811,749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-046788 · form4.xml · nonDerivative · entry 1

Torti Frank · CIK 0001647805 · President and Vant Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,911,927

F1 · kind: Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.

F1 · price: Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.

SEC source: 0001140361-25-046601 · form4.xml · nonDerivative · entry 1

Pulik Richard · CIK 0001885841 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386,144

F1 · shares: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

SEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 5

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,353,113

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 4

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,542,651

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 3

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,697,727

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325355 · ownership.xml · nonDerivative · entry 5

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,353,113

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325355 · ownership.xml · nonDerivative · entry 4

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,542,651

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325355 · ownership.xml · nonDerivative · entry 3

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,697,727

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325343 · ownership.xml · nonDerivative · entry 5

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,353,113

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325343 · ownership.xml · nonDerivative · entry 4

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,542,651

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325343 · ownership.xml · nonDerivative · entry 3

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 16,697,727

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001140361-25-046247 · form4.xml · derivative · entry 4

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,304,198

Underlying: Common Shares · 59,513 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

SEC source: 0001140361-25-046247 · form4.xml · nonDerivative · entry 3

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,836,547

F2 · shares: Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.

F1 · price: All options exercised by the reporting person would have expired in March 2026 if not exercised. The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

SEC source: 0001140361-25-046247 · form4.xml · nonDerivative · entry 2

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,869,229

F1 · price: All options exercised by the reporting person would have expired in March 2026 if not exercised. The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

SEC source: 0001140361-25-046247 · form4.xml · nonDerivative · entry 1

Sukhatme Mayukh · CIK 0001750050 · Director · President & CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,896,060

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 2

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,130,445

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325359 · ownership.xml · nonDerivative · entry 1

Gold Daniel Allen · CIK 0001832142 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,772,727

F1 · ownership.direct: The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325355 · ownership.xml · nonDerivative · entry 2

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,130,445

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325355 · ownership.xml · nonDerivative · entry 1

MANCHESTER KEITH S · CIK 0001244828 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,772,727

F1 · ownership.direct: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325343 · ownership.xml · nonDerivative · entry 2

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,130,445

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001193125-25-325343 · ownership.xml · nonDerivative · entry 1

QVT Financial LP · CIK 0001290162 · Director by Deputization

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by QVT Financial Investment Cayman Ltd.

Disclosed balance after: 17,772,727

F1 · ownership.direct: Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.

F2 · ownership.nature: QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

SEC source: 0001635075-25-000006 · primary_doc.xml · derivative · entry 13

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,150,227

Underlying: Common Stock · 832,453 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: All options exercised by the reporting person would have expired in March 2026 if not exercised.

F6 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 9

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,653,755

F2 · shares: Represents the "net settlement" by the Issuer of options previously granted to the reporting person in order to satisfy the exercise price applicable to such options.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.88 to $22.49, inclusive.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 8

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,132,463

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.88 to $22.49, inclusive.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 7

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,486,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-045906 · form4.xml · derivative · entry 12

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,272,852 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

SEC source: 0001140361-25-045906 · form4.xml · derivative · entry 11

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,363,711 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

SEC source: 0001140361-25-045906 · form4.xml · derivative · entry 10

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 234,096 shares

Expires 2026-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Award of stock options to purchase Common Shares that is fully vested.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 9

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,287,081

F2 · shares: Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 8

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,616,406

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 7

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,559,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 6

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,287,081

F2 · shares: Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 5

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,084,676

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 4

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,650,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 3

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,287,081

F2 · shares: Represents the "net settlement" by the Issuer of stock options previously granted to the reporting person in order to satisfy the exercise price applicable to such stock options.

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 2

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,290,820

F1 · price: All options exercised by the reporting person would have expired in March or April 2026 if not exercised. The transactions reported on this Form 4 represent the disposition of the entirety of the reporting person's stock options expiring in 2026. As of the date of this filing, the reporting person has disgorged to the Issuer the full amount of the disgorgable profits realized from the sale reported herein, as required by Section 16(b) of the Securities Exchange Act of 1934.

SEC source: 0001140361-25-045906 · form4.xml · nonDerivative · entry 1

Gline Matthew · CIK 0001750094 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,521,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001635075-25-000006 · primary_doc.xml · derivative · entry 12

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,982,680

Underlying: Common Stock · 4,672,724 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: All options exercised by the reporting person would have expired in March 2026 if not exercised.

F6 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 6

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,653,755

F2 · shares: Represents the "net settlement" by the Issuer of options previously granted to the reporting person in order to satisfy the exercise price applicable to such options.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.65 to $22.13, inclusive.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 5

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,350,621

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.65 to $22.13, inclusive.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 4

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,326,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001635075-25-000006 · primary_doc.xml · derivative · entry 11

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,655,404

Underlying: Common Stock · 1,869,691 shares

Expires 2026-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: All options exercised by the reporting person would have expired in March 2026 if not exercised.

F6 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of December 27, 2019. These options vest and become exercisable (i) 25% on the first anniversary of the applicable vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 3

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,653,755

F2 · shares: Represents the "net settlement" by the Issuer of options previously granted to the reporting person in order to satisfy the exercise price applicable to such options.

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.35 to $22.05, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 2

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,749,305

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.35 to $22.05, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

SEC source: 0001635075-25-000006 · primary_doc.xml · nonDerivative · entry 1

Ramaswamy Vivek · CIK 0001635075 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,523,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001140361-25-045279 · form4.xml · derivative · entry 3

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,876,523

Underlying: Common Stock · 200,000 shares

Expires 2032-04-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).

SEC source: 0001140361-25-045279 · form4.xml · nonDerivative · entry 2

Venker Eric · CIK 0001801917 · President & Immunovant CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,497,908

F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025.